Cancer Anorexia-Cachexia Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cancer Anorexia Cachexia Syndrome Pipeline Drugs Market Overview
The Cancer Anorexia-Cachexia Syndrome pipeline market report provides a comprehensive overview of the therapeutics under development for Cancer Anorexia-Cachexia Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects.
Key Targets in the Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market
In the Cancer Anorexia-Cachexia Syndrome pipeline drugs market, the key targets are Growth Hormone Secretagogue Receptor Type 1, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Growth/Differentiation Factor 15, 5-Hydroxytryptamine Receptor 1A, Beta 1 Adrenergic Receptor, Beta 2 Adrenergic Receptor, Cell Death Activator CIDE A, GDNF Family Receptor Alpha Like, and GTPase KRas.
Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market
Growth Hormone Secretagogue Receptor Type 1 Agonist has the highest number of pipeline products followed by Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Growth/Differentiation Factor 15 Inhibitor, 5-Hydroxytryptamine Receptor 1A Antagonist, Beta 1 Adrenergic Receptor Antagonist, Beta 2 Adrenergic Receptor Agonist, Beta 2 Adrenergic Receptor Antagonist, Cell Death Activator CIDE A Inhibitor, GDNF Family Receptor Alpha Like Antagonist, and GTPase KRas Inhibitor.
Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market Analysis, by MoA
To get more insights on key MoA, download a free sample report
Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Cancer Anorexia-Cachexia Syndrome pipeline drug market are Oral, Subcutaneous, Intravenous, and Sublingual. Oral has the maximum number of pipeline products.
Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market
The key molecule types in the Cancer Anorexia-Cachexia Syndrome pipeline drugs market are small molecule, monoclonal antibody, synthetic peptide, cell therapy, recombinant peptide, antibody, biologic, fusion protein, and gene therapy. Small molecule has the highest number of pipeline products.
Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market, by Molecule Types
To get more insights on key molecule types, download a free sample report
Major Companies in the Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market
The major companies in the Cancer Anorexia-Cachexia Syndrome pipeline drugs market are Helsinn Group, AAVogen Inc, Abreos Biosciences Inc, Actimed Therapeutics Ltd, Aeterna Zentaris Inc, Aphios Corp, Artelo Biosciences Inc, AtoGen Co Ltd, AVEO Pharmaceuticals Inc, and Betula Pharma.
Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Cancer Anorexia-Cachexia Syndrome Pipeline Drugs Market Overview
Key Targets | Growth Hormone Secretagogue Receptor Type 1, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Growth/Differentiation Factor 15, 5-Hydroxytryptamine Receptor 1A, Beta 1 Adrenergic Receptor, Beta 2 Adrenergic Receptor, Cell Death Activator CIDE A, GDNF Family Receptor Alpha Like, and GTPase KRas |
Key Mechanisms of action | Growth Hormone Secretagogue Receptor Type 1 Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Growth/Differentiation Factor 15 Inhibitor, 5-Hydroxytryptamine Receptor 1A Antagonist, Beta 1 Adrenergic Receptor Antagonist, Beta 2 Adrenergic Receptor Agonist, Beta 2 Adrenergic Receptor Antagonist, Cell Death Activator CIDE A Inhibitor, GDNF Family Receptor Alpha Like Antagonist, and GTPase KRas Inhibitor |
Key Routes of Administration | Oral, Subcutaneous, Intravenous, and Sublingual |
Key Molecule Types | Small Molecule, Monoclonal Antibody, Synthetic Peptide, Cell Therapy, Recombinant Peptide, Antibody, Biologic, Fusion Protein, and Gene Therapy |
Major Companies | Helsinn Group, AAVogen Inc, Abreos Biosciences Inc, Actimed Therapeutics Ltd, Aeterna Zentaris Inc, Aphios Corp, Artelo Biosciences Inc, AtoGen Co Ltd, AVEO Pharmaceuticals Inc, and Betula Pharma |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Cancer Anorexia-Cachexia Syndrome
- The pipeline guide reviews pipeline therapeutics for Cancer Anorexia-Cachexia Syndrome by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Cancer Anorexia-Cachexia Syndrome therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Cancer Anorexia-Cachexia Syndrome therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Cancer Anorexia-Cachexia Syndrome
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Cancer Anorexia-Cachexia Syndrome
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Cancer Anorexia-Cachexia Syndrome pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Abreos Biosciences Inc
Actimed Therapeutics Ltd
Aeterna Zentaris Inc
Aphios Corp
Artelo Biosciences Inc
AtoGen Co Ltd
AVEO Pharmaceuticals Inc
Betula Pharma
Byomass Inc
Cannabics Pharmaceuticals Inc
Creative Medical Technology Holdings Inc
Endevica Bio
Extend Biosciences Inc
FibroGenesis LLC
Helsinn Group
Immuneering Corp
Larix Bioscience LLC
MGC Pharmaceuticals Ltd
NGM Biopharmaceuticals Inc
Oncocross Co Ltd
Oneness Biotech Co Ltd
Paradigm Biopharmaceuticals Ltd
Pfizer Inc
RaQualia Pharma Inc
Signablok Inc
Vascular BioSciences
Zeria Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Cancer Anorexia-Cachexia Syndrome pipeline drugs market?
In the Cancer Anorexia-Cachexia Syndrome pipeline drugs market the key targets are Growth Hormone Secretagogue Receptor Type 1, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Growth/Differentiation Factor 15, 5-Hydroxytryptamine Receptor 1A, Beta 1 Adrenergic Receptor, Beta 2 Adrenergic Receptor, Cell Death Activator CIDE A, GDNF Family Receptor Alpha Like, and GTPase KRas.
-
What are the key mechanisms of action in the Cancer Anorexia-Cachexia Syndrome pipeline drugs market?
In the Cancer Anorexia-Cachexia Syndrome pipeline drugs market the key mechanisms of action are Growth Hormone Secretagogue Receptor Type 1 Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Growth/Differentiation Factor 15 Inhibitor, 5-Hydroxytryptamine Receptor 1A Antagonist, Beta 1 Adrenergic Receptor Antagonist, Beta 2 Adrenergic Receptor Agonist, Beta 2 Adrenergic Receptor Antagonist, Cell Death Activator CIDE A Inhibitor, GDNF Family Receptor Alpha Like Antagonist, and GTPase KRas Inhibitor.
-
What are the key routes of administration in the Cancer Anorexia-Cachexia Syndrome pipeline drugs market?
The key routes of administration in the Cancer Anorexia-Cachexia Syndrome pipeline drug market are Oral, Subcutaneous, Intravenous, and Sublingual. Oral has the maximum number of pipeline products.
-
What are the key molecule types in the Cancer Anorexia-Cachexia Syndrome pipeline drugs market?
The key molecule types in the Cancer Anorexia-Cachexia Syndrome pipeline drug market are Small Molecule, Monoclonal Antibody, Synthetic Peptide, Cell Therapy, Recombinant Peptide, Antibody, Biologic, Fusion Protein, and Gene Therapy.
-
What are the major companies in the Cancer Anorexia-Cachexia Syndrome pipeline drugs market?
In the Cancer Anorexia-Cachexia Syndrome pipeline drugs market the major companies are Helsinn Group, AAVogen Inc, Abreos Biosciences Inc, Actimed Therapeutics Ltd, Aeterna Zentaris Inc, Aphios Corp, Artelo Biosciences Inc, AtoGen Co Ltd, AVEO Pharmaceuticals Inc, and Betula Pharma.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.